Researchers at the University of Texas at El Paso have found that popular weight-loss medications known as GLP-1 receptor agonists are associated with lower rates of substance use disorders
Researchers are responsible for complying with all applicable UK laws, regulations, and institutional laboratory practices.
Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK
An efficient biological system (or a well-formulated supplement) uses the enzyme glutathione reductase to convert GSSG back into GSH, creating a continuous cycle of protection that maintains a healthy redox balance
doi: 10.1021/acs.biochem.9b00160 271 SenPLanYLiCYSidoliSDonahueGDouZet al